Pharmaceutical Industry

Drug Development Drug Pricing Drug Manufacturing Manufacturing Market Trends Generic Drugs Clinical Trials Drug Safety Market Competition Vaccine Development

Collegium to Acquire AZSTARYS for $650 Million, Adding Second ADHD Medicine

Financing will combine cash with a delayed‑draw term loan to deliver immediate adjusted EBITDA accretion.

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Roche Launches Nvidia-Powered AI Factory With 2,176 New Blackwell GPUs, Claims Pharma’s Largest Footprint

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

Novo Nordisk Extends Weight‑Loss Lead as Amgen’s Once‑Monthly MariTide Reaches Phase 3

CVS Threatens To Close 134 Tennessee Pharmacies as PBM-Separation Bill Advances

Investor Law Firms Rally uniQure Case as April 13 Lead-Plaintiff Deadline Nears

AbbVie to Invest $380 Million in Two North Chicago API Plants

Novo Nordisk Slumps on Weak 2026 Outlook as GLP-1 Pill Uptake Builds

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

Sanofi Ousts CEO Paul Hudson, Taps Belén Garijo as Successor

AstraZeneca Posts Strong 2025 Results, Sees Further Growth in 2026

Lilly and Innovent Forge Territory-Split Cancer and Immunology Alliance

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Lilly, Repertoire Strike Up-to-$1.93 Billion Autoimmune Drug Pact

AstraZeneca Pledges $15 Billion China Expansion Through 2030

J&J Joins White House Drug-Price Pact, Wins Tariff Relief

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

GSK Chief Says U.S. Is Best Place to Invest as UK Softens Drug Pricing Rules